Skip to main content
Annolyse
Back to companies

SVR · NZX

Savor (SVR)

Consumer / HospitalityCovered: HY21 - FY2610 published briefings

Savor is an NZX-listed consumer / hospitality company. Its latest covered result is FY26, with HY21 - FY26 of source-backed result history on Annolyse.

Sections

Latest result

Latest metrics

FY26, released 26 May 2026

← Swipe to view more
SVR latest metrics
MetricValueChange
Revenue$55.2m↓ -2.6%
EBITDA$8m↑ +10.3%
NPAT$1.3m↑ +208.3%
Operating cash flow$6.9m↓ -3.2%
OCF / EBITDA %85.8%↓ -11.9pp
Net debt$6.3m↓ -12.2%
Net debt / EBITDA0.79xOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.06x, range 1.00x-4.03x.↓ -20.2%
ROE %6.9%Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.↑ +13.9pp
PBT$1.8m↑ +228.6%
FCF pre-lease$4.6m↓ -20.1%

Source: latest published briefing (FY26, released 26 May 2026). Change compares against the prior equivalent period: FY25, released 22 May 2025.

Valuation

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 18 September 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$13.8m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

10.63x

i

Recent market cap compared with trailing earnings.

EPS

0.02

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

2.52x

i

Enterprise value compared with recent EBITDA.

P/FCF

2.99x

i

Market cap compared with recent free cash flow.

P/B

0.74x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Ask about SVR

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more
SVR metric history
MetricFY2612 MONTHS26 May 2026FY2512 MONTHS22 May 2025FY2412 MONTHS22 May 2024HY246 MONTHS28 November 2023FY2312 MONTHS25 May 2023HY236 MONTHS23 November 2022FY2212 MONTHS27 May 2022HY226 MONTHS18 November 2021FY2112 MONTHS28 May 2021HY216 MONTHS27 November 2020Trend
Revenue$55.2m$56.6m$61.9m$29.1m$52.4m$20.7m$30.6m$17.2m$16.1m$9.9m
Chart
Revenue growth %-2.6%-8.4%18.1%40.4%71.3%20.7%89.5%Unprecedented high revenue growth. 89.5%; 5-period range -57.8% to 71.3%. Revenue growth: 89.5%, unprecedented high; 5-period mean 4.1%, range -57.8%-71.3%.73.3%Outside range high revenue growth. 73.3%; 3-period range -45% to 40.4%. Revenue growth: 73.3%, above normal range; 3-period mean 5.4%, range -45.0%-40.4%.-57.8%Unprecedented low revenue growth. -57.8%; 5-period range -8.4% to 89.5%. Revenue growth: -57.8%, unprecedented low; 5-period mean 33.6%, range -8.4%-89.5%.-45.0%Outside range low revenue growth. -45%; 3-period range 20.7% to 73.3%. Revenue growth: -45.0%, below normal range; 3-period mean 44.8%, range 20.7%-73.3%.
Chart
EBITDA$8m$7.3m$8.8m$3.1m$5.2m$1.4m$3m$2.1m$1.8m$0.69m
Chart
EBITDA margin %14.5%Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.12.8%14.2%10.7%10.0%6.8%Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.9.8%Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.12.3%Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.11.4%6.9%
Chart
  • FY26 EBITDA margin %: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.
PBT$1.8m-$1.4m-$2.9m-$0.4m-$2.3m-$2.1m-$5m-$0.8m-$3.1m-$0.4m
Chart
NPAT$1.3m-$1.2m$0.7m-$0.4m-$2.3m-$2.1m-$5m-$0.8m-$6.6m-$0.4m
Chart
Operating cash flow$6.9m$7.1m$6.4m$2.5m$6.1m$1.6m$3m$1.1m$0.01m-$0.14m
Chart
OCF / EBITDA %85.8%97.7%73.0%81.8%116.2%Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.117.3%Outside range high ocf / ebitda cash conversion. 117.3%; 3-period range -20.8% to 81.8%. OCF / EBITDA cash conversion: 117.3%, above normal range; 3-period mean 38.2%, range -20.8%-81.8%.98.6%53.5%0.7%Unprecedented low ocf / ebitda cash conversion. 0.7%; 5-period range 73% to 116.2%. OCF / EBITDA cash conversion: 0.7%, unprecedented low; 5-period mean 94.3%, range 73.0%-116.2%.-20.8%
Chart
  • FY23 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.
FCF pre-lease$4.6m$5.8m$5.9m—$1.8m-$0.73m$1m-$0.03m-$1.3m-$0.56m
Chart
DPS—-9.0c-8.0c-11.0c-13.0c-16.0c-18.0c——16.0c
Chart
ROE %6.9%Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.-7.0%3.6%-2.5%Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.-13.5%-14.9%Outside range low roe. -14.9%; 3-period range -4% to -2.5%. ROE: -14.9%, below normal range; 3-period mean -3.0%, range -4.0%--2.5%.-35.1%Unprecedented low roe. -35.1%; 4-period range -13.5% to 6.9%. ROE: -35.1%, unprecedented low; 4-period mean -2.5%, range -13.5%-6.9%.-4.0%-51.9%-2.6%
Chart
  • HY24 ROE %: Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.
  • FY26 ROE %: Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.
Net debt$6.3m$7.2m$9.1m—$11.9m$13.8m$12.1m$11.5m$3.6m$5.2m
Chart
Net debt / EBITDA0.79xOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.06x, range 1.00x-4.03x.0.99x1.03x—2.27x9.84x4.03xUnprecedented high net debt / ebitda. 4.03x; 5-period range 0.79x to 2.27x. Net debt / EBITDA: 4.03x, unprecedented high; 5-period mean 1.41x, range 0.79x-2.27x.5.45x1.97x7.55x
Chart
  • FY26 Net debt / EBITDA: Outside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.06x, range 1.00x-4.03x.
Debtor days111—3—3n/m5Unprecedented high debtor days. 5d; 5-period range 1d to 3d. Debtor days: 4.7 days, unprecedented high; 5-period mean 1.5 days, range 0.5 days-3.2 days.4
Chart
Inventory days665Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.67127810Unprecedented high inventory days. 10d; 5-period range 5d to 7d. Inventory days: 10.4 days, unprecedented high; 5-period mean 6.2 days, range 5.3 days-7.4 days.28
Chart
  • FY24 Inventory days: Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.
Total assets$49.6m$51.6m$53.8m$56.7m$56.4m$54.9m$55m$59.6m$36.4m$42.1m
Chart

Reference: annolyse.ai/companies/svr

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...
  • HY21 SVR HY: Outside range low revenue growth. -45%; 3-period range 20.7% to 73.3%. Revenue growth: -45.0%, below normal range; 3-period mean 44.8%, range 20.7%-73.3%.
  • HY22 SVR HY: Outside range high revenue growth. 73.3%; 3-period range -45% to 40.4%. Revenue growth: 73.3%, above normal range; 3-period mean 5.4%, range -45.0%-40.4%.
  • FY21 SVR FY: Unprecedented low revenue growth. -57.8%; 5-period range -8.4% to 89.5%. Revenue growth: -57.8%, unprecedented low; 5-period mean 33.6%, range -8.4%-89.5%.
  • FY22 SVR FY: Unprecedented high revenue growth. 89.5%; 5-period range -57.8% to 71.3%. Revenue growth: 89.5%, unprecedented high; 5-period mean 4.1%, range -57.8%-71.3%.

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...
  • HY22 SVR HY: Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.
  • HY23 SVR HY: Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.
  • FY22 SVR FY: Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.
  • FY26 SVR FY: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...
  • HY23 SVR HY: Outside range high ocf / ebitda cash conversion. 117.3%; 3-period range -20.8% to 81.8%. OCF / EBITDA cash conversion: 117.3%, above normal range; 3-period mean 38.2%, range -20.8%-81.8%.
  • FY21 SVR FY: Unprecedented low ocf / ebitda cash conversion. 0.7%; 5-period range 73% to 116.2%. OCF / EBITDA cash conversion: 0.7%, unprecedented low; 5-period mean 94.3%, range 73.0%-116.2%.
  • FY23 SVR FY: Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...
  • HY23 SVR HY: Outside range low roe. -14.9%; 3-period range -4% to -2.5%. ROE: -14.9%, below normal range; 3-period mean -3.0%, range -4.0%--2.5%.
  • HY24 SVR HY: Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.
  • FY22 SVR FY: Unprecedented low roe. -35.1%; 4-period range -13.5% to 6.9%. ROE: -35.1%, unprecedented low; 4-period mean -2.5%, range -13.5%-6.9%.
  • FY26 SVR FY: Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...
  • FY22 SVR FY: Unprecedented high net debt / ebitda. 4.03x; 5-period range 0.79x to 2.27x. Net debt / EBITDA: 4.03x, unprecedented high; 5-period mean 1.41x, range 0.79x-2.27x.
  • FY26 SVR FY: Outside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.06x, range 1.00x-4.03x.

DPS

Dividend per share declared for the period.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...
  • FY21 SVR FY: Unprecedented high debtor days. 5d; 5-period range 1d to 3d. Debtor days: 4.7 days, unprecedented high; 5-period mean 1.5 days, range 0.5 days-3.2 days.

Inventory days

Inventory days where the working-capital inputs are source-backed.

Loading chart...
  • FY21 SVR FY: Unprecedented high inventory days. 10d; 5-period range 5d to 7d. Inventory days: 10.4 days, unprecedented high; 5-period mean 6.2 days, range 5.3 days-7.4 days.
  • FY24 SVR FY: Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...

The setup & the reality

FY25 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY25 said to watch

Previous analysisFY25Result releasedAnnolyse analysis published

From PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

No forward targets, FY26 guidance or forward-work disclosures are provided in this release, so the result cannot be benchmarked against management's own goals. The shape of the year is, however, distinctive: HY25 revenue was up over 40% on a depressed HY24 base, yet full-year revenue fell 8.4%, which implies H2 revenue of roughly $27.6m against an unusually strong H2 FY24. EBITDA was second-half weighted at the group level (H1 contributed only 43.2% of full-year EBITDA), so second-half profitability held up better than second-half revenue.

The gap that matters is the second-half revenue decline against last year's stronger comparable. The release attributes this to "reduced [activity per] head" but does not quantify volume, mix or pricing components, leaving the underlying demand trajectory into FY26 unclear.

Open questions

Open questions from FY25

  • What drove the second-half revenue decline against H2 FY24, and is the lower per-head spend a structural mix shift or a cyclical demand effect?
  • Why did the effective tax rate fall from 122.8% to 16.1%, and what is the expected normalised rate now that prior-year tax credits appear to have unwound?
  • How should investors read the 174.7% capex step-up to $1.3m – is this catch-up maintenance, new venue development, or the start of a sustained higher reinvestment level?
  • Why was no final dividend declared (payment date "Not Applicable") given the move to net cash, and what is the framework for resuming distributions?
  • Will the lower below-EBITDA cost base (D&A and finance costs roughly $3.0m lower year-on-year) persist, or does it reflect one-off items that won't repeat?

This briefing cannot assess the underlying volume, pricing and venue-level economics behind the second-half revenue decline because the release does not disclose them.

Latest result sources

Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

Savor Annual Report 2026

FY26 / financial report

Savor Annual Results - Market Announcement

FY26 / results release

Savor Annual Results - NZX Appendix 2

FY26 / results announcement

Prior comparable period

Savor Annual Report 2025

FY25 / financial report

Savor Annual Results - Market Announcement

FY25 / results release

Savor Annual Results - NZX Appendix 2

FY25 / results announcement

Interim context

Savor Interim Financial Statements

HY26 / financial report

Savor Interim Results - Appendix 2

HY26 / results announcement

Savor Interim Results Announcement

HY26 / results release

Release context

Savor 2023 Annual Meeting results

HY26 / commentary

Peer context

Other covered Consumer companies

These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.

CMO · FY26

The Colonial Motor Company

11 published result briefings

BGP · HY27

Briscoe Group

10 published result briefings

HLG · HY26

Hallenstein Glasson

10 published result briefings

MCK · HY26

Millennium & Copthorne Hotels New Zealand

10 published result briefings

Compare SVR, CMO, BGP, HLG →Consumer result archiveNZX retail comparison

Archive

Briefing archive

The full chronological archive contains every published result briefing.

FY26 · Released 26 May 2026

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Read briefing

FY25 · Released 22 May 2025

PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

Revenue fell 8.4% and EBITDA dropped 17.2%, yet operating cash flow rose 10.9% as a smaller tax benefit drove NPAT into the red.

Read briefing

FY24 · Released 22 May 2024

NPAT flipped positive on 122.7% tax rate while PBT loss widened 22.5%

EBITDA rose 68.1% on 18.1% revenue growth, but the headline profit reflects an unprecedented tax benefit rather than improvement at the pre-tax line.

Read briefing

HY24 · Released 28 November 2023

EBITDA up 130% on 40.4% revenue growth, leverage halved to 4.4x

Operating leverage drove margin expansion and deleveraging, but the group remained loss-making and HY23 was only 26% of FY23 EBITDA.

Read briefing

FY23 · Released 25 May 2023

Revenue up 71.3% but comparison base was reshaped by acquisition and disposal

EBITDA margin slipped to 10.0% against a historical average of 12.4% even as revenue rose 71.3% off a non-comparable prior year.

Read briefing

HY23 · Released 23 November 2022

Savor's PBT swings to a $2.1m loss as leverage climbs to 9.8x EBITDA

Revenue rose 20.7% but PBT fell 183.1% and net debt to EBITDA rose to 9.8x, testing balance-sheet flexibility.

Read briefing
Open all 10 result briefings

Related insights

Compare this company

The latest SVR metrics also appear in these cross-company comparisons.

Insight

Cash conversion quality

This result converted 85.8% of EBITDA to operating cash flow, -11.9pp versus the prior comparable period.

Open insight

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 16.8pp, with a distortion flag in the result.

Open insight

Insight

Leverage and balance-sheet risk

Net debt / EBITDA is 0.79x, -0.20x versus the prior comparable period.

Open insight

Insight

ROE and capital efficiency

ROE was 6.9%, +13.9pp versus the prior comparable period.

Open insight

Get notified when SVR publishes

Get the next Savor result briefing and five-year history updates by email.